Barbara Ameer
Impact in
- Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Pharmacology and Obesity Treatment
- Hematology top 5%
- Platelet Disorders and Treatments
- Blood groups and transfusion
Papers in
- Pharmacology 19
- Drug-Induced Hepatotoxicity and Protection 9
- Pharmacogenetics and Drug Metabolism 7
- Pharmacology and Obesity Treatment 4
-
- Pharmaceutical studies and practices 5
- Pharmacological Effects and Toxicity Studies 4
- Co-authors
- Randy A. Weintraub (3 shared papers)David J. Greenblatt (10 shared papers)Marcia Divoll (9 shared papers)Jodie V. Johnson (2 shared papers)Richard A. Yost (2 shared papers)Russell L. Rouseff (1 shared paper)Darrell R. Abernethy (3 shared papers)Richard I. Shader (2 shared papers)
- Journals
- The Journal of Clinical Pharmacology (7 papers)Clinical Pharmacology & Therapeutics (5 papers)Blood Advances (4 papers)American Journal of Health-System Pharmacy (4 papers)Journal of Pharmacology and Experimental Therapeutics (2 papers)
- Partner nations
- United StatesCanadaIreland
In The Last Decade
Barbara Ameer
49 papers receiving 2.0k citations
Barbara Ameer's Hit Papers
Peers
Comparison fields: 5 of 130
- Pharmacology 553
- Hematology 366
- Biochemistry 137
- Anesthesiology and Pain Medicine 89
- Pharmacology 258
Countries citing papers authored by Barbara Ameer
This map shows the geographic impact of Barbara Ameer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Barbara Ameer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Barbara Ameer more than expected).
Fields of papers citing papers by Barbara Ameer
This network shows the impact of papers produced by Barbara Ameer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Barbara Ameer. The network helps show where Barbara Ameer may publish in the future.
Co-authors
The 25 scholars most cited alongside Barbara Ameer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 51 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease Hit paper breakdown → | 2021 | 355 |
| 2 | 1997 | 300 | |
| 3 | 1996 | 273 | |
| 4 | 1982 | 107 | |
| 5 | 1977 | 104 | |
| 6 | 1982 | 90 | |
| 7 | 1981 | 86 | |
| 8 | 1985 | 75 | |
| 9 | 1983 | 73 | |
| 10 | 1981 | 73 | |
| 11 | 1983 | 68 | |
| 12 | 1986 | 65 | |
| 13 | 2010 | 55 | |
| 14 | 1982 | 50 | |
| 15 | 1982 | 49 | |
| 16 | Increased metabolic clearance of acetaminophen with oral contraceptive use. | 1982 | 39 |
| 17 | 2021 | 30 | |
| 18 | 2021 | 28 | |
| 19 | 2021 | 28 | |
| 20 | 2016 | 24 |
About Barbara Ameer
Barbara Ameer is a scholar working on Pharmacology, Pharmacology, Pediatrics, Perinatology and Child Health, Hematology and Endocrinology, Diabetes and Metabolism, having authored 51 papers that have together received 2.2k indexed citations. Recurring topics across this work include Drug-Induced Hepatotoxicity and Protection (9 papers), Pharmacogenetics and Drug Metabolism (7 papers), Pharmaceutical studies and practices (5 papers), Platelet Disorders and Treatments (5 papers), Pharmacology and Obesity Treatment (4 papers), Pharmacological Effects and Toxicity Studies (4 papers), Blood groups and transfusion (3 papers) and Epilepsy research and treatment (3 papers). The work is most often cited by research in Pharmacology (553 citations), Hematology (366 citations), Biochemistry (137 citations), Anesthesiology and Pain Medicine (89 citations) and Pharmacology (258 citations). Barbara Ameer has collaborated with scholars based in United States, Canada and Ireland. Frequent co-authors include Randy A. Weintraub, David J. Greenblatt, Marcia Divoll, Jodie V. Johnson, Richard A. Yost, Russell L. Rouseff, Darrell R. Abernethy, Richard I. Shader, Leon Shargel and Sandra L. Haberichter. Their work appears in journals such as The Journal of Clinical Pharmacology, Clinical Pharmacology & Therapeutics, Blood Advances, American Journal of Health-System Pharmacy and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.